Celltex News
Stem Cell Journals: Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood
Celltex Therapeutics Corporation was mentioned in the Stem Cell Journals publication in an article titled "Development of COVID‐19 Therapies from Birthing Tissues and Cord Blood".
Read the article
Tags: clinical research, clinical trial, COVID-19, stem cell therapy
More Recent News
From Totipotent to Unipotent: Understanding Stem Cell Types and Differentiation Potential
Although stem cell therapy’s future applications and potential are still being investigated, stem cells have revolutionized the landscape of medicine, offering a promising therapy option for many conditions and diseases.
However, if you’re interested in receiving stem cell therapy in the future, be aware that not all stem cells are the same. It’s important to understand the differences between various types of stem cells and which ones are utilized in regenerative medicine.
Read MoreWhat Is Stem Cell Banking?
Thanks to advancements in stem cell research, particularly the recognition of the regenerative properties of Mesenchymal Stem Cells (MSCs), Adult Stem Cell Banking has become a versatile and promising avenue for accessing personalized healthcare and future therapeutic interventions.
In this article, we describe the Stem Cell Banking process in detail and explain how it may greatly increase the potential for positive results when therapeutic application is necessary.
Read More